Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment o

Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary…

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies#Press #Release…

Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains

Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains #Denali #ALS #Primary #Endpoint #Failure #Path…

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory…